Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Oct;19(10):675.
doi: 10.1038/s41584-023-01013-4.

Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

Kristofer Andréasson  1 , Viggo Hamberg  2 , Jenny Wigén  3 , Gunilla Westergren-Thorsson  3
Affiliations
Comment

Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

Kristofer Andréasson et al. Nat Rev Rheumatol. 2023 Oct.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Pope, J. E. et al. State-of-the-art evidence in the treatment of systemic sclerosis. Nat. Rev. Rheumatol. 19, 212–226 (2023). - DOI - PubMed - PMC
    1. Rydell-Törmänen, K. et al. Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis. Lab. Invest. 92, 917–925 (2012). - DOI - PubMed
    1. Wigén, J., Elowsson-Rendin, L., Karlsson, L., Tykesson, E. & Westergren-Thorsson, G. Glycosaminoglycans: a link between development and regeneration in the lung. Stem Cells Dev. 28, 823–832 (2019). - DOI - PubMed
    1. Morath, C. et al. Antifibrotic actions of mycophenolic acid. Clin. Transplant. 20, 25–29 (2006). - DOI - PubMed
    1. Roos, N. et al. In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil. J. Pharmacol. Exp. Ther. 321, 583–589 (2007). - DOI - PubMed

Substances

LinkOut - more resources